After many articles about vaccines mistrust from healthcare workers, now the same from China.
Sinovac might release its phase 3 human trial data on Wednesday but little else is known publicly about the vaccine candidates. We are in the same position in Occident regarding Moderna and Pfizer. The sole pieces of information are printed in reports from the state agencies which delivered their agreements…Meaning obvious bias and in the USA, the Chamber is questioning the procedure of the Trump administration to get this approval…
If high-risk profiles are not committed, who will be? As mentioned in a previous post, the key period for the adoption will be during the second injection period.